Cardiopulmonary coupling in chronic obstructive pulmonary disease: The role of imaging

Journal of Thoracic Imaging

Volumn 29, Issue 2, 2014, Pages 80-91

  Rahaghi, Farbod N ^a   Van Beek, Edwin J R ^b   Washko, George R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

COPD; echocardiography; heart disease; imaging; MRI; perfusion; PET; pulmonary hypertension

Indexed keywords

ECHOCARDIOGRAPHY; HEART; HUMANS; LUNG; MAGNETIC RESONANCE IMAGING; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR DISEASES;

EID: 84894424344     PISSN: 08835993     EISSN: 15360237     Source Type: Journal    
DOI: 10.1097/RTI.0000000000000076     Document Type: Conference Paper

References (90)

1. Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186:155-161.
2. Minai OA, Chaouat A, Adnot S. Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective. Chest. 2010;137(suppl): 39S-51S.
3. Barr RG, Ahmed FS, Carr JJ, et al. Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA Lung Study. Eur Respir J. 2012;39:846-854.
4. Budoff MJ, Nasir K, Kinney GL, et al. Coronary artery and thoracic calcium on noncontrast thoracic CT scans: comparison of ungated and gated examinations in patients from the COPD Gene cohort. J Cardiovasc Comput Tomogr. 2011;5: 113-118.
5. Santos S, Peinado VI, Ramirez J, et al. Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD. Eur Respir J. 2002;19:632-638.
6. Barbera JA. Mechanisms of development of chronic obstructive pulmonary disease-associated pulmonary hypertension. Pulm Circ. 2013;3:160-164.
7. Fayngersh V, Drakopanagiotakis F, Dennis McCool F, et al. Pulmonary hypertension in a stable community-based COPD population. Lung. 2011;189:377-382.
8. Thabut G, Dauriat G, Stern JB, et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest. 2005;127: 1531-1536.
9. Scharf SM, Iqbal M, Keller C, et al. Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med. 2002;166:314-322.
10. Weitzenblum E, Kessler R, Oswald M, et al. Medical treatment of pulmonary hypertension in chronic lung disease. Eur Respir J. 1994;7:148-152.
11. Oswald-Mammosser M, Weitzenblum E, Quoix E, et al. Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest. 1995;107:1193-1198.
12. Kessler R, Faller M, Weitzenblum E, et al. "Natural history" of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease. Am J Respir Crit Care Med. 2001;164:219-224.
13. Sims MW, Margolis DJ, Localio AR, et al. Impact of pulmonary artery pressure on exercise function in severe COPD. Chest. 2009;136:412-419.
14. Shepard JM, Gropper MA, Nicolaysen G, et al. Lung microvascular pressure profile measured by micropuncture in anesthetized dogs. J Appl Physiol (1985). 1988;64:874-879.
15. Sciurba FC, Rogers RM, Keenan RJ, et al. Improvement in pulmonary function and elastic recoil after lung-reduction surgery for diffuse emphysema. N Engl J Med. 1996;334: 1095-1099.
16. Criner GJ, Scharf SM, Falk JA, et al. Effect of lung volume reduction surgery on resting pulmonary hemodynamics in severe emphysema. Am J Respir Crit Care Med. 2007;176: 253-260.
17. Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J. 2008;32:1371-1385.
18. McAllister DA, Maclay JD, Mills NL, et al. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;176:1208-1214.
19. Barr RG. The epidemiology of vascular dysfunction relating to chronic obstructive pulmonary disease and emphysema. Proc Am Thorac Soc. 2011;8:522-527.
20. Hale KA, Niewoehner DE, Cosio MG. Morphologic changes in the muscular pulmonary arteries: relationship to cigarette smoking, airway disease, and emphysema. Am Rev Respir Dis. 1980;122:273-278.
21. Wright JL, Petty T, Thurlbeck WM. Analysis of the structure of the muscular pulmonary arteries in patients with pulmonary hypertension and COPD: National Institutes of Health nocturnal oxygen therapy trial. Lung. 1992;170:109-124.
22. Hopkins N, McLoughlin P. The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis? J Anat. 2002;201:335-348.
23. Van Beek EJR, Mirsadraee S, Murchison JT. Radiology of chronic obstructive pulmonary disease. In: A M.P.a.H, ed. A Colour Atlas for COPD. NY: Clinical Publishing; 2013. In press.
24. Voelkel NF, Douglas IS, Nicolls M. Angiogenesis in chronic lung disease. Chest. 2007;131:874-879.
25. Maclay JD, McAllister DA, Rabinovich R, et al. Systemic elastin degradation in chronic obstructive pulmonary disease. Thorax. 2012;67:606-612.
26. Fisher MR, Criner GJ, Fishman AP, et al. Estimating pulmonary artery pressures by echocardiography in patients with emphysema. Eur Respir J. 2007;30:914-921.
27. Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation. 1984;70:657-662.
28. Tramarin R, Torbicki A, Marchandise B, et al. Doppler echocardiographic evaluation of pulmonary artery pressure in chronic obstructive pulmonary disease. A European multicentre study. Working Group on Noninvasive Evaluation of Pulmonary Artery Pressure. European Office of the World Health Organization, Copenhagen. Eur Heart J. 1991;12: 103-111.
29. Jorgensen K, Houltz E, Westfelt U, et al. Effects of lung volume reduction surgery on left ventricular diastolic filling and dimensions in patients with severe emphysema. Chest. 2003;124:1863-1870.
30. Arcasoy SM, Christie JD, Ferrari VA, et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med. 2003;167: 735-740.
31. Watz H, Waschki B, Meyer T, et al. Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest. 2010;138:32-38.
32. Williams MC, Murchison J, Edwards LD, et al. Artery calcification is increased in patients with COPD and associated with increased mortality and morbidity. Thorax. 2013. In press.
33. Mapel DW, Dedrick D, Davis K. Trends and cardiovascular co-morbidities of COPD patients in the Veterans Administration Medical System, 1991-1999. COPD. 2005;2:35-41.
34. Tei C, Nishimura RA, Seward JB, et al. Noninvasive Dopplerderived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements. J Am Soc Echocardiogr. 1997;10:169-178.
35. Curkendall SM, DeLuise C, Jones JK, et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol. 2006;16:63-70.
36. Di Bello V, Conte L, Delle Donne MG, et al. Advantages of real time three-dimensional echocardiography in the assessment of right ventricular volumes and function in patients with pulmonary hypertension compared with conventional twodimensional echocardiography. Echocardiography. 2013;30: 820-828.
37. Rajagopalan N, Simon MA, Shah H, et al. Utility of right ventricular tissue Doppler imaging: correlation with right heart catheterization. Echocardiography. 2008;25:706-711.
38. Leitman M, Lysyansky P, Sidenko S, et al. Two-dimensional strain-a novel software for real-time quantitative echocardiographic assessment of myocardial function. J Am Soc Echocardiogr. 2004;17:1021-1029.
39. Leong DP, Grover S, Molaee P, et al. Nonvolumetric echocardiographic indices of right ventricular systolic function: validation with cardiovascular magnetic resonance and relationship with functional capacity. Echocardiography. 2012;29: 455-463.
40. Russell K, Eriksen M, Aaberge L, et al. A novel clinical method for quantification of regional left ventricular pressurestrain loop area: a non-invasive index of myocardial work. Eur Heart J. 2012;33:724-733.
41. Hardegree EL, Sachdev A, Villarraga HR, et al. Role of serial quantitative assessment of right ventricular function by strain in pulmonary arterial hypertension. Am J Cardiol. 2013; 111:143-148.
42. Motoji Y, Tanaka H, Fukuda Y, et al. Efficacy of right ventricular free-wall longitudinal speckle-tracking strain for predicting long-term outcome in patients with pulmonary hypertension. Circ J. 2013;77:756-763.
43. Vonk-Noordegraaf A, Marcus JT, Holverda S, et al. Early changes of cardiac structure and function in COPD patients with mild hypoxemia. Chest. 2005;127:1898-1903.
44. Holverda S, Rietema H, Westerhof N, et al. Stroke volume increase to exercise in chronic obstructive pulmonary disease is limited by increased pulmonary artery pressure. Heart. 2009; 95:137-141.
45. Marcus JT, Vonk Noordegraaf A, De Vries PM, et al. MRI evaluation of right ventricular pressure overload in chronic obstructive pulmonary disease. J Magn Reson Imaging. 1998;8:999-1005.
46. Swift AJ, Rajaram S, Hurdman J, et al. Noninvasive estimation of PA pressure, flow, and resistance with CMR imaging: derivation and prospective validation study from the ASPIRE registry. JACC Cardiovasc Imaging. 2013;6: 1036-1047.
47. Carlsen J, Hasseriis Andersen K, Boesgaard S, et al. Pulmonary arterial lesions in explanted lungs after transplantation correlate with severity of pulmonary hypertension in chronic obstructive pulmonary disease. J Heart Lung Transplant. 2013; 32:347-354.
48. Stevens GR, Garcia-Alvarez A, Sahni S, et al. RV dysfunction in pulmonary hypertension is independently related to pulmonary artery stiffness. JACC Cardiovasc Imaging. 2012;5: 378-387.
49. Jacobson G, Turner AF, Balchum OJ, et al. Vascular changes in pulmonary emphysema. The radiologic evaluation by selective and peripheral pulmonary wedge angiography. Am J Roentgenol Radium Ther Nucl Med. 1967;100:374-396.
50. Magee F, Wright JL, Wiggs BR, et al. Pulmonary vascular structure and function in chronic obstructive pulmonary disease. Thorax. 1988;43:183-189.
51. Kuriyama K, Gamsu G, Stern RG, et al. CT-determined pulmonary artery diameters in predicting pulmonary hypertension. Invest Radiol. 1984;19:16-22.
52. Ng CS, Wells AU, Padley SP. A CT sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter. J Thorac Imaging. 1999;14:270-278.
53. Wells JM, Washko GR, Han MK, et al. Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med. 2012;367:913-921.
54. Revel MP, Faivre JB, Remy-Jardin M, et al. Pulmonary hypertension: ECG-gated 64-section CT angiographic evaluation of new functional parameters as diagnostic criteria. Radiology. 2009;250:558-566.
55. Paz R, Mohiaddin RH, Longmore DB. Magnetic resonance assessment of the pulmonary arterial trunk anatomy, flow, pulsatility and distensibility. Eur Heart J. 1993;14:1524-1530.
56. Ertan C, Tarakci N, Ozeke O, et al. Pulmonary artery distensibility in chronic obstructive pulmonary disease. Echocardiography. 2013;30:940-944.
57. Fourie PR, Coetzee AR, Bolliger CT. Pulmonary artery compliance: its role in right ventricular-arterial coupling. Cardiovasc Res. 1992;26:839-844.
58. Vonk Noordegraaf A, Naeije R. Right ventricular function in scleroderma-related pulmonary hypertension. Rheumatology (Oxford). 2008;47(suppl 5):v42-v43.
59. Engelke C, et al. High-resolution CT and CT angiography of peripheral pulmonary vascular disorders. Radiographics. 2002;22:739-764.
60. Matsuoka S, Washko GR, Yamashiro T, et al. Pulmonary hypertension and computed tomography measurement of small pulmonary vessels in severe emphysema. Am J Respir Crit Care Med. 2010;181:218-225.
61. Estepar RS, Ross JC, Krissian K, et al. Computational vascular morphometry for the assessment of pulmonary vascular disease based on scale-space particles. Proc IEEE Int Symp Biomed Imaging. 2012;1479-1482.
62. Estepar RS, Kinney GL, Black-Shinn JL, et al. Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications. Am J Respir Crit Care Med. 2013;188:231-239.
63. Rabinovitch M, Keane JF, Fellows KE, et al. Quantitative analysis of the pulmonary wedge angiogram in congenital heart defects. Correlation with hemodynamic data and morphometric findings in lung biopsy tissue. Circulation. 1981;63:152-164.
64. Junqueira FP, Lima CM, Coutinho AC Jr, et al. Pulmonary arterial hypertension: an imaging review comparing MR pulmonary angiography and perfusion with multidetector CT angiography. Br J Radiol. 2012;85:1446-1456.
65. Schoepf UJ, Savino G, Lake DR, et al. The age of CT pulmonary angiography. J Thorac Imaging. 2005;20:273-279.
66. Johnson TR, Krauss B, Sedlmair M, et al. Material differentiation by dual energy CT: initial experience. Eur Radiol. 2007;17:1510-1517.
67. Remy-Jardin M, Faivre JB, Pontana F, et al. Thoracic applications of dual energy. Radiol Clin North Am. 2010;48: 193-205.
68. Ghaye B, Monville J-F. "Case 2 - Assessment of Perfusion Defects", Appearing in Brochure "Dual Energy CT: SOMATOM Definition" Order No. A91CT-00615-04C1-7600. Erlangen Germany: Siemens AG; 2008.
69. Hoey ET, Mirsadraee S, Pepke-Zaba J, et al. Dual-energy CT angiography for assessment of regional pulmonary perfusion in patients with chronic thromboembolic pulmonary hypertension: initial experience. Am J Roentgenol. 2011;196: 524-532.
70. Pontana F, Faivre JB, Remy-Jardin M, et al. Lung perfusion with dual-energy multidetector-row CT (MDCT): feasibility for the evaluation of acute pulmonary embolism in 117 consecutive patients. Acad Radiol. 2008;15:1494-1504.
71. Pansini V, Remy-Jardin M, Faivre JB, et al. Assessment of lobar perfusion in smokers according to the presence and severity of emphysema: preliminary experience with dualenergy CT angiography. Eur Radiol. 2009;19:2834-2843.
72. Lu GM, Zhao Y, Zhang LJ, et al. Dual-energy CT of the lung. Am J Roentgenol. 2012;199(suppl):S40-S53.
73. Washko GR, Parraga G, Coxson HO. Quantitative pulmonary imaging using computed tomography and magnetic resonance imaging. Respirology. 2012;17:432-444.
74. Ohno Y, Hatabu H, Murase K, et al. Quantitative assessment of regional pulmonary perfusion in the entire lung using threedimensional ultrafast dynamic contrast-enhanced magnetic resonance imaging: Preliminary experience in 40 subjects. J Magn Reson Imaging. 2004;20:353-365.
75. Ohno Y, Hatabu H, Murase K, et al. Primary pulmonary hypertension: 3D dynamic perfusion MRI for quantitative analysis of regional pulmonary perfusion. Am J Roentgenol. 2007;188:48-56.
76. Ley S, Mereles D, Puderbach M, et al. Value of MR phasecontrast flow measurements for functional assessment of pulmonary arterial hypertension. Eur Radiol. 2007;17: 1892-1897.
77. Ley S, Fink C, Zaporozhan J, et al. Value of high spatial and high temporal resolution magnetic resonance angiography for differentiation between idiopathic and thromboembolic pulmonary hypertension: initial results. Eur Radiol. 2005;15: 2256-2263.
78. Schuster DP, Mintun MA. Studying the pulmonary circulation with positron emission tomography. J Thorac Imaging. 1988; 3:15-24.
79. Harris RS, Schuster DP. Visualizing lung function with positron emission tomography. J Appl Physiol (1985). 2007; 102:448-458.
80. Vidal Melo MF, Winkler T, Harris RS, et al. Spatial heterogeneity of lung perfusion assessed with (13)N PET as a vascular biomarker in chronic obstructive pulmonary disease. J Nucl Med. 2010;51:57-65.
81. Zielinski J, Tobiasz M, Hawrylkiewicz I, et al. Effects of longterm oxygen therapy on pulmonary hemodynamics in COPD patients: a 6-year prospective study. Chest. 1998;113:65-70.
82. Fujimoto K, Matsuzawa Y, Yamaguchi S, et al. Benefits of oxygen on exercise performance and pulmonary hemodynamics in patients with COPD with mild hypoxemia. Chest. 2002;122:457-463.
83. Park J, Song JH, Park DA, et al. Systematic review and metaanalysis of pulmonary hypertension specific therapy for exercise capacity in chronic obstructive pulmonary disease. J Korean Med Sci. 2013;28:1200-1206.
84. Archer SL, Mike D, Crow J, et al. A placebo-controlled trial of prostacyclin in acute respiratory failure in COPD. Chest. 1996;109:750-755.
85. Nana-Sinkam SP, Lee JD, Sotto-Santiago S, et al. Prostacyclin prevents pulmonary endothelial cell apoptosis induced by cigarette smoke. Am J Respir Crit Care Med. 2007;175: 676-685.
86. Shimizu M, Imanishi J, Takano T, et al. Disproportionate pulmonary hypertension in a patient with early-onset pulmonary emphysema treated with specific drugs for pulmonary arterial hypertension. Intern Med. 2011;50:2341-2346.
87. Stolz D, Rasch H, Linka A, et al. A randomised, controlled trial of bosentan in severe COPD. Eur Respir J. 2008;32:619-628.
88. Bjortuft O, Simonsen S, Geiran OR, et al. Pulmonary haemodynamics after single-lung transplantation for end-stage pulmonary parenchymal disease. Eur Respir J. 1996;9: 2007-2011.
89. Romme EA, Murchison JT, Edwards LD, et al. CT-measured bone attenuation in patients with chronic obstructive pulmonary disease: relation to clinical features and outcomes. J Bone Miner Res. 2013;28:1369-1377.
90. Jorgensen K, Muller MF, Nel J, et al. Reduced intrathoracic blood volume and left and right ventricular dimensions in patients with severe emphysema: an MRI study. Chest. 2007; 131:1050-1057.